Graeme Boyter, DO
Pain Medicine · Springfield, MONPI 1649830126
Payments from drug & device makers
What this record shows
This record is dominated by grants: $5,000 of the $6,054 with a category attached, or 82.6%. Medtronic accounts for 87.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $5,124 and has fallen 94.7% since, to $272 in 2025.
Across 30 payments — averaging $201.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Nevro Corp.$214
- AbbVie$138
- Globus Medical$128
- SPR Therapeutics, Inc$118
- Abbott$58
- plus $90 from 3 others
What the payments were for
- Grants$5,00083%
- Food & beverage$1,05417%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $5,309 |
| Nevro Corp. | 4 | $214 |
| AbbVie | 6 | $138 |
| Globus Medical | 4 | $128 |
| SPR Therapeutics, Inc | 2 | $118 |
| Abbott | 2 | $58 |
| Titan Surgical Group, LLC | 1 | $52 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| GE HealthCare | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$5,000
- INTELLIS ADAPTIVESTIM$178
- Senza$130
How this compares
$6,054 in reported general payments places this provider in the 75th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 16 | $528 |
| Tizanidine Hcl | 12 | $202 |
| Meloxicam | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Springfield
- Cameron HessSpringfield$13K
- Sadie GieddSpringfield$9K
- Clairese TomaSpringfield$5K
- Ronald EllisSpringfield$3K
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
- Jooyoung MaengSaint Louis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.